Response to BotulinumtoxinA in a migraine cohort with multiple comorbidities and widespread pain
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Response to BotulinumtoxinA in a migraine cohort with multiple comorbidities and widespread pain
Authors
Keywords
-
Journal
REGIONAL ANESTHESIA AND PAIN MEDICINE
Volume 44, Issue 6, Pages 660-668
Publisher
BMJ
Online
2019-05-17
DOI
10.1136/rapm-2018-100196
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study
- (2017) Elif Ilgaz Aydinlar et al. JOURNAL OF HEADACHE AND PAIN
- Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
- (2016) David W. Dodick et al. HEADACHE
- A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability
- (2016) Richard B. Lipton et al. HEADACHE
- Treatment of chronic daily headache with comorbid anxiety and depression using botulinum toxin A: a prospective pilot study
- (2016) Hongwei Zhang et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Evidence from diverse clinical populations supported clinical validity of PROMIS pain interference and pain behavior
- (2016) Robert L. Askew et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions
- (2016) Karon F. Cook et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Real-life data in 115 chronic migraine patients treated with Onabotulinumtoxin A during more than one year
- (2016) I. Aicua-Rapun et al. JOURNAL OF HEADACHE AND PAIN
- Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment
- (2016) Simona Guerzoni et al. JOURNAL OF HEADACHE AND PAIN
- Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting
- (2016) Katja Kollewe et al. JOURNAL OF NEURAL TRANSMISSION
- United States National Pain Strategy for Population Research: Concepts, Definitions, and Pilot Data
- (2016) Michael Von Korff et al. JOURNAL OF PAIN
- Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine
- (2016) Bekir Enes Demiryurek et al. NEUROLOGICAL SCIENCES
- The use of onabotulinum toxin A (Botox®) in the treatment of chronic migraine at the Parma Headache Centre: a prospective observational study
- (2016) Marco Russo et al. NEUROLOGICAL SCIENCES
- Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine
- (2015) Kasra Maasumi et al. HEADACHE
- Frequency of Migraine Headaches in Patients With Fibromyalgia
- (2015) Brinder Vij et al. HEADACHE
- Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study
- (2015) Dawn C. Buse et al. HEADACHE
- O051. Chronic migraine and onabotulinumtoxinA: a prospective study on patients treated at the Headache Centre of the Padua University and analysis of possible predictors of responsivity
- (2015) Caterina Disco et al. JOURNAL OF HEADACHE AND PAIN
- A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience
- (2015) Andrea Negro et al. JOURNAL OF HEADACHE AND PAIN
- Physical and Psychological Correlates of Fatigue and Physical Function: A Collaborative Health Outcomes Information Registry (CHOIR) Study
- (2015) John A. Sturgeon et al. JOURNAL OF PAIN
- OnabotulinumtoxinA treatment for chronic migraine: experience in 52 patients treated with the PREEMPT paradigm
- (2015) María Isabel Pedraza et al. SpringerPlus
- Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: What happens after one year?
- (2014) Eva Cernuda-Morollón et al. CEPHALALGIA
- Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK
- (2014) Modar Khalil et al. JOURNAL OF HEADACHE AND PAIN
- From Catastrophizing to Recovery: a pilot study of a single-session treatment for pain catastrophizing
- (2014) Beth Darnall et al. Journal of Pain Research
- Efficacy, safety, and predictors of response to botulinum toxin type A in refractory chronic migraine: A retrospective study
- (2013) Kuan-Hsiang Lin et al. Journal of the Chinese Medical Association
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
- (2010) SK Aurora et al. CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
- (2010) HC Diener et al. CEPHALALGIA
- Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
- (2010) D C Buse et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search